Merck Immunotherapy Drug Shines In Lung Cancer Study – NPR
WMFE |
Merck Immunotherapy Drug Shines In Lung Cancer Study
NPR There's encouraging news for cancer treatments that stimulate the immune system to attack cancer cells. A widely used immunotherapy drug appears to be useful in a greater number of patients with lung cancer. The drug called Keytruda, or pembrolizumab … Immunotherapy Might Improve Survival Outcomes in Late-Stage Lung Cancer Patients Opinion | The Problem With Miracle Cancer Cures – The New York … 'Super Bowl of lung cancer immunotherapy' |
